chr14:38058757:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr14:38,058,757-38,064,454 |
| hg38 | chr14:37,589,552-37,595,249 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| <0.001 | squamous cell carcinoma | NA | BeFree | Detail | |
| <0.001 | Diabetes Mellitus, Non-Insulin-Dependent | Identification of a regulatory variant that binds FOXA1 and FOXA2 at the CDC123/... | BeFree | 25211022 | Detail |
| <0.001 | Esophageal Neoplasms | NA | BeFree | Detail | |
| 0.120 | Fatty Liver | NA | BeFree,CTD_human | Detail | |
| <0.001 | Liver neoplasms | NA | BeFree | Detail | |
| <0.001 | Lung Neoplasms | NA | BeFree | Detail | |
| 0.001 | Neoplasm Metastasis | NA | BeFree | Detail | |
| <0.001 | osteoporosis | NA | BeFree | Detail | |
| 0.123 | Prostatic Neoplasms | NA | BeFree,CTD_human,LHGDN | Detail | |
| <0.001 | Supernumerary structure | NA | BeFree | Detail | |
| <0.001 | Thyroid Neoplasm | NA | BeFree | Detail | |
| <0.001 | esophageal carcinoma | NA | BeFree | Detail | |
| <0.001 | Tumor Progression | Furthermore, MT1DP was revealed as a negative regulator of Alfa-fetoprotein (AFP... | BeFree | 25261601 | Detail |
| <0.001 | Metastatic malignant neoplasm to brain | NA | BeFree | Detail | |
| <0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
| <0.001 | Anaplastic thyroid carcinoma | NA | BeFree | Detail | |
| 0.002 | Malignant neoplasm of lung | We studied the transcriptional repression of DNMT3B by forkhead O transcription ... | BeFree | 25122426 | Detail |
| <0.001 | Prostate cancer recurrent | NA | BeFree | Detail | |
| <0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and R... | BeFree | 25261601 | Detail |
| <0.001 | Invasive lobular breast carcinoma | Besides E-cadherin loss, the best known ILC genetic hallmark, we identified muta... | BeFree | 26451490 | Detail |
| <0.001 | Prostatic Intraepithelial Neoplasias | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of liver | Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and R... | BeFree | 25261601 | Detail |
| <0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
| 0.006 | Malignant neoplasm of prostate | Taken together, our data illustrate the mechanistic details by which cooperativi... | BeFree | 24875621 | Detail |
| 0.006 | Malignant neoplasm of prostate | The transcriptional network of the androgen receptor (AR), a key molecule of pro... | BeFree | 25329375 | Detail |
| 0.006 | Malignant neoplasm of prostate | In particular, we described the use of Epidaurus to (i) integrate epigenetic dat... | BeFree | 25378314 | Detail |
| 0.006 | Malignant neoplasm of prostate | The effect of EAF2 and/or FOXA1 knockdown on LNCaP human prostate cancer cell pr... | BeFree | 25808853 | Detail |
| <0.001 | Non-alcoholic Fatty Liver Disease | NA | BeFree | Detail | |
| <0.001 | endometrial carcinoma | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of esophagus | NA | BeFree | Detail | |
| <0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
| 0.002 | Carcinogenesis | These findings suggest that regulation of the AR signaling pathway, cell prolife... | BeFree | 25808853 | Detail |
| 0.005 | prostate carcinoma | Taken together, our data illustrate the mechanistic details by which cooperativi... | BeFree | 24875621 | Detail |
| 0.005 | prostate carcinoma | The transcriptional network of the androgen receptor (AR), a key molecule of pro... | BeFree | 25329375 | Detail |
| 0.005 | prostate carcinoma | In particular, we described the use of Epidaurus to (i) integrate epigenetic dat... | BeFree | 25378314 | Detail |
| 0.005 | prostate carcinoma | The effect of EAF2 and/or FOXA1 knockdown on LNCaP human prostate cancer cell pr... | BeFree | 25808853 | Detail |
| 0.008 | breast carcinoma | Taken together, these data define the importance of AGR2 in breast cancer cell g... | BeFree | 25100862 | Detail |
| 0.008 | breast carcinoma | In addition, the results are consistent with the notion that parity-associated e... | BeFree | 25234841 | Detail |
| 0.008 | breast carcinoma | Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulti... | BeFree | 25422910 | Detail |
| 0.008 | breast carcinoma | FOXA1 repression is associated with loss of BRCA1 and increased promoter methyla... | BeFree | 25531315 | Detail |
| 0.008 | breast carcinoma | FOXA1 positively regulates gene expression by changing gene methylation status i... | BeFree | 25755696 | Detail |
| 0.002 | Carcinoma of lung | We studied the transcriptional repression of DNMT3B by forkhead O transcription ... | BeFree | 25122426 | Detail |
| <0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
| <0.001 | Carcinoma of bladder | MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer. | BeFree | 25071007 | Detail |
| <0.001 | Adenoviral infections | NA | BeFree | Detail | |
| <0.001 | Ductal Carcinoma | NA | BeFree | Detail | |
| <0.001 | pancreatic ductal adenocarcinoma | NA | BeFree | Detail | |
| 0.138 | Mammary Neoplasms | Integrated analysis of the global gene methylation and expression profiles of a ... | BeFree,CTD_human,LHGDN | 25531315 | Detail |
| <0.001 | uterine corpus cancer | NA | BeFree | Detail | |
| <0.001 | liver carcinoma | Here we used an integrative strategy to examine the hypothesis that genetic vari... | BeFree | 25198130 | Detail |
| 0.004 | adenocarcinoma | NA | BeFree,LHGDN | Detail | |
| <0.001 | Malignant neoplasm of urinary bladder | MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer. | BeFree | 25071007 | Detail |
| 0.011 | Malignant neoplasm of breast | Taken together, these data define the importance of AGR2 in breast cancer cell g... | BeFree,GAD | 25100862 | Detail |
| 0.011 | Malignant neoplasm of breast | In addition, the results are consistent with the notion that parity-associated e... | BeFree,GAD | 25234841 | Detail |
| 0.011 | Malignant neoplasm of breast | Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulti... | BeFree,GAD | 25422910 | Detail |
| 0.011 | Malignant neoplasm of breast | FOXA1 repression is associated with loss of BRCA1 and increased promoter methyla... | BeFree,GAD | 25531315 | Detail |
| 0.011 | Malignant neoplasm of breast | FOXA1 positively regulates gene expression by changing gene methylation status i... | BeFree,GAD | 25755696 | Detail |
| <0.001 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of thyroid | NA | BeFree | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| Identification of a regulatory variant that binds FOXA1 and FOXA2 at the CDC123/CAMK1D type 2 diabet... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Furthermore, MT1DP was revealed as a negative regulator of Alfa-fetoprotein (AFP), a classic liver c... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We studied the transcriptional repression of DNMT3B by forkhead O transcription factor 3a (FOXO3a) i... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA... | DisGeNET | Detail |
| Besides E-cadherin loss, the best known ILC genetic hallmark, we identified mutations targeting PTEN... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Taken together, our data illustrate the mechanistic details by which cooperativity and equilibrium w... | DisGeNET | Detail |
| The transcriptional network of the androgen receptor (AR), a key molecule of prostate cancer, is fre... | DisGeNET | Detail |
| In particular, we described the use of Epidaurus to (i) integrate epigenetic data from prostate canc... | DisGeNET | Detail |
| The effect of EAF2 and/or FOXA1 knockdown on LNCaP human prostate cancer cell proliferation and migr... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| These findings suggest that regulation of the AR signaling pathway, cell proliferation, and migratio... | DisGeNET | Detail |
| Taken together, our data illustrate the mechanistic details by which cooperativity and equilibrium w... | DisGeNET | Detail |
| The transcriptional network of the androgen receptor (AR), a key molecule of prostate cancer, is fre... | DisGeNET | Detail |
| In particular, we described the use of Epidaurus to (i) integrate epigenetic data from prostate canc... | DisGeNET | Detail |
| The effect of EAF2 and/or FOXA1 knockdown on LNCaP human prostate cancer cell proliferation and migr... | DisGeNET | Detail |
| Taken together, these data define the importance of AGR2 in breast cancer cell growth and highlight ... | DisGeNET | Detail |
| In addition, the results are consistent with the notion that parity-associated epigenetic silencing ... | DisGeNET | Detail |
| Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes ... | DisGeNET | Detail |
| FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin s... | DisGeNET | Detail |
| FOXA1 positively regulates gene expression by changing gene methylation status in human breast cance... | DisGeNET | Detail |
| We studied the transcriptional repression of DNMT3B by forkhead O transcription factor 3a (FOXO3a) i... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Integrated analysis of the global gene methylation and expression profiles of a set of 33 familial b... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Here we used an integrative strategy to examine the hypothesis that genetic variants at FOXA1/2 bind... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer. | DisGeNET | Detail |
| Taken together, these data define the importance of AGR2 in breast cancer cell growth and highlight ... | DisGeNET | Detail |
| In addition, the results are consistent with the notion that parity-associated epigenetic silencing ... | DisGeNET | Detail |
| Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes ... | DisGeNET | Detail |
| FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin s... | DisGeNET | Detail |
| FOXA1 positively regulates gene expression by changing gene methylation status in human breast cance... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- Genome
- hg19
- Position
- chr14:38,058,757-38,064,454
- Variant Type
- snv
Genome browser